Edward James

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Cervical Cancer Screening

Endoplasmic Reticulum

Regulatory T Cells

Top Venues

The Journal of biological chemistry

Cancer immunology, immunotherapy : CII

Immunotherapy advances

Cancer immunology research

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Imperial College London

United Kingdom

PHD

University of Bristol

United Kingdom

BSC

Publications

Samuel Luke Hill, Gessa Sugiyarto, Jack Harrington, Edward James, Timothy J Underwood, Tim Elliott
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma. Cancer immunology, immunotherapy : CII 73 (11) (2024)
Gessa Sugiyarto, David Prossor, Osman Dadas, E David Arcia-Anaya, Tim Elliott, Edward James
Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cells. Immunotherapy advances 1 (1) (2020)
Emma Reeves, Oliver Wood, Christian Hermann Ottensmeier, Emma V King, Gareth J Thomas, Tim Elliott, Edward James
HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC. Cancer immunology research 7 (7) (2019)
Athanasios Papakyriakou, Emma Reeves, Mary Beton, Halina Mikolajek, Leon Douglas, Grace Cooper, Tim Elliott, Jörn M Werner, Edward James
The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1. The Journal of biological chemistry 293 (20) (2018)